The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions.If you have any queries about the SPCs on our website then please e-mail

Clindabactin 55 mg chewable tablets for dogs and cats

55 mg/tablet Chewable tablet

Dechra Regulatory B.V.VPA22622/027/001

Main Information

Trade NameClindabactin 55 mg chewable tablets for dogs and cats
Active SubstancesClindamycin
Strength55 mg/tablet
Dosage FormChewable tablet
Licence HolderDechra Regulatory B.V.
Licence NumberVPA22622/027/001

Group Information

ATC CodeQJ01FF01 clindamycin
Therapeutic ClassAntibacterial


Licence Issued18/04/2019
Legal StatusPOM: Prescription Only Medicine as defined in relevant national legislation


Summary of Product CharacteristicsPDF Version
Package LeafletNo document available
Public Assessment ReportNo document available
« Back